References
- Fizazi K, Greco FA, Pavlidis N, Pentheroudakis G; ESMO Guidelines Working Group. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2011;22 Suppl 6:vi64-68.
- Stoyianni A, Pentheroudakis G, Pavlidis N. Neuroendocrine carcinoma of unknown primary: a systematic review of the literature and a comparative study with other neuroendocrine tumors. Cancer Treat Rev 2011;37:358-365. https://doi.org/10.1016/j.ctrv.2011.03.002
- Spigel DR, Hainsworth JD, Greco FA. Neuroendocrine carcinoma of unknown primary site. Semin Oncol 2009;36:52-59. https://doi.org/10.1053/j.seminoncol.2008.10.003
- Tot T. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors. Cancer 1999;85:171-177. https://doi.org/10.1002/(SICI)1097-0142(19990101)85:1<171::AID-CNCR24>3.0.CO;2-V
- Tot T. Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma. Eur J Cancer 2002;38:758-763. https://doi.org/10.1016/S0959-8049(02)00008-4
- Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 2003;39:1990-2005. https://doi.org/10.1016/S0959-8049(03)00547-1
- Rindi G, D'Adda T, Froio E, Fellegara G, Bordi C. Prognostic factors in gastrointestinal endocrine tumors. Endocr Pathol 2007;18:145-149. https://doi.org/10.1007/s12022-007-0020-x
- Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934-959. https://doi.org/10.1002/cncr.11105
- Norheim I, Oberg K, Th eodorsson-Norheim E, Lindgren PG, Lundqvist G, Magnusson A, et al. Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production, and survival. Ann Surg 1987;206:115-125. https://doi.org/10.1097/00000658-198708000-00001
- Oberg K, Eriksson B. Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol 2005;19:753-781. https://doi.org/10.1016/j.bpg.2005.06.002
- Starker LF, Carling T. Molecular genetics of gastroenteropancreatic neuroendocrine tumors. Curr Opin Oncol 2009;21:29-33. https://doi.org/10.1097/CCO.0b013e328319ea7b
- McDermott EW, Guduric B, Brennan MF. Prognostic variables in patients with gastrointestinal carcinoid tumours. Br J Surg 1994;81:1007-1009. https://doi.org/10.1002/bjs.1800810725
- Th ompson GB, van Heerden JA, Grant CS, Carney JA, Ilstrup DM. Islet cell carcinomas of the pancreas: a twenty-year experience. Surgery 1988;104:1011-1017.
- Zeitels J, Naunheim K, Kaplan EL, Straus F 2nd. Carcinoid tumors: a 37-year experience. Arch Surg 1982;117:732-737. https://doi.org/10.1001/archsurg.1982.01380290176031
- Wang SC, Parekh JR, Zuraek MB, Venook AP, Bergsland EK, Warren RS, et al. Identification of unknown primary tumors in patients with neuroendocrine liver metastases. Arch Surg 2010;145:276-280. https://doi.org/10.1001/archsurg.2010.10
Cited by
- Submucosal small-cell neuroendocrine carcinoma of the larynx detected using 18 F-fluorodeoxyglucose positron emission tomography/computed tomography: A case report and review of the litera vol.8, pp.3, 2011, https://doi.org/10.3892/ol.2014.2246